Trial Profile
Switching from Posaconazole (POSA) Suspension to Tablets in Patients with Hematologic Malignancy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Sep 2019
Price :
$35
*
At a glance
- Drugs Posaconazole (Primary) ; Posaconazole (Primary)
- Indications Mycoses
- Focus Adverse reactions; Pharmacokinetics
- 16 Sep 2019 Results published in the Antimicrobial Agents and Chemotherapy.
- 30 Nov 2015 New trial record